E-LIB Suche - Ergebnisse für: Paolo Tarantino

1

Immunotherapy for Early-Stage Triple Negative Breast Cancer..:

Song, Fei ; Tarantino, Paolo ; Garrido-Castro, Ana...
Current Oncology Reports. 26 (2024) 1 - p. 21-33 , 2024

Link: https://doi.org/10.1007/..

2

Author Correction: Adjuvant nivolumab, capecitabine or the ..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Evolution of HER2 expression between pre-treatment biopsy a..:

Tarantino, Paolo ; Ajari, Ogheneochuko ; Graham, Noah...
European Journal of Cancer. 201 (2024) - p. 113920 , 2024

Link: https://doi.org/10.1016/..

4

Prognosis and treatment outcomes for patients with stage IA..:

Tarantino, Paolo ; Leone, Julieta ; Vallejo, Carlos T....
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Exploring a Novel Approach to Spare Classic Chemotherapy in..:

Scafuri, Luca ; Buonerba, Carlo ; Di Lauro, Vincenzo...
Oncology and Therapy. , 2024

Link: https://doi.org/10.1007/..

6

Effect of age on safety and efficacy of novel cancer drugs ..:

Nicolò, Eleonora ; Gandini, Sara ; Giugliano, Federica...
European Journal of Cancer. 207 (2024) - p. 114181 , 2024

Link: https://doi.org/10.1016/..

7

Prevalence and spectrum of germline BRCA1 and BRCA2 in a co..:

De Matteis, Elisabetta ; Tumolo, Maria Rosaria ; Tarantino, Paolo...
Oncotarget. 15 (2024) 1 - p. 134-141 , 2024

Link: https://doi.org/10.18632..

8

Adjuvant nivolumab, capecitabine or the combination in pati..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

9

Invasive lobular breast cancer: Focus on prevention, geneti..:

Corso, Giovanni ; Fusco, Nicola ; Guerini-Rocco, Elena...
Seminars in Oncology. , 2024

Link: https://doi.org/10.1053/..

10

Resistance to Antibody-Drug Conjugates Targeting HER2 in Br..:

Guidi, Lorenzo ; Pellizzari, Gloria ; Tarantino, Paolo..
Cancers. 15 (2023) 4 - p. 1130 , 2023

Link: https://doi.org/10.3390/..

11

Tailoring the Treatment of Early-stage HER2-positive Breast..:

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA ; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy...
Oncology & Haematology. 19 (2023) 1 - p. 11 , 2023

Link: https://doi.org/10.17925..

12

Evaluation of the Geographical Accessibility of Genome-Matc..:

Crimini, Edoardo ; Tini, Giulia ; Tarantino, Paolo...
The Oncologist. 29 (2023) 2 - p. 159-165 , 2023

Link: https://doi.org/10.1093/..

13

Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine an..:

Mittal, Abhenil ; Molto Valiente, Consolacion ; Tamimi, Faris...
Cancers. 15 (2023) 7 - p. 2015 , 2023

Link: https://doi.org/10.3390/..

14

Opportunities and Challenges for a Histology-Agnostic Utili..:

Neupane, Niraj ; Thapa, Sangharsha ; Bhattarai, Abhinav...
Current Oncology Reports. , 2023

Link: https://doi.org/10.1007/..

15

The HER2-low revolution in breast oncology: steps forward a..:

Nicolò, Eleonora ; Boscolo Bielo, Luca ; Curigliano, Giuseppe.
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592311528 , 2023

Link: https://doi.org/10.1177/..